Track the BioArctic AB (publ) stock price and the full insider trade history of the company, a listed equity based in Finland. Shares are listed on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, BioArctic AB (publ) has recorded 0 reports. Market capitalisation: €27.2bn. Every trade is free.
Analysts rate BioArctic AB (publ) Hold (neutral), based on 5 analysts. Average price target: SEK 301.40.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
0 of 0 declarations
BioArctic AB (publ) is a Swedish biopharmaceutical company focused on developing treatments for neurodegenerative diseases. It is listed on the Stockholm Stock Exchange (XSTO).